Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Slaney CY"'
Autor:
Chan JD; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Scheffler CM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Munoz I; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Sek K; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Lee JN; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Huang YK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Yap KM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Saw NYL; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Li J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Chen AXY; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Chan CW; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Derrick EB; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Todd KL; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Tong J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Dunbar PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Li J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Hoang TX; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., de Menezes MN; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Petley EV; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Kim JS; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Nguyen D; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Leung PSK; School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia., So J; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Deguit C; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Zhu J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., House IG; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Kats LM; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Scott AM; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia.; Faculty of Medicine, The University of Melbourne, Parkville, Victoria, Australia., Solomon BJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Harrison SJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.; Clinical Haematology and Centre of Excellence for Cellular Immunotherapies, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Oliaro J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Parish IA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Quinn KM; School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia.; Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia., Neeson PJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Slaney CY; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Lai J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. junyun.lai@unimelb.edu.au.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia. junyun.lai@unimelb.edu.au., Beavis PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. paul.beavis@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia. paul.beavis@petermac.org., Darcy PK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. phil.darcy@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia. phil.darcy@petermac.org.; Clinical Haematology and Centre of Excellence for Cellular Immunotherapies, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia. phil.darcy@petermac.org.; Department of Immunology, Monash University, Clayton, Victoria, Australia. phil.darcy@petermac.org.
Publikováno v:
Nature [Nature] 2024 May; Vol. 629 (8010), pp. 201-210. Date of Electronic Publication: 2024 Apr 10.
Autor:
Pappas EG; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia., Kershaw MH; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia., Slaney CY; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Feb 19; Vol. 15 (4). Date of Electronic Publication: 2023 Feb 19.
Autor:
Slaney CY; Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia., Luo P; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China., Kong FM; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong SAR, China.; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Guo L; Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China., Zhang J; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Jan 12; Vol. 13, pp. 1129623. Date of Electronic Publication: 2023 Jan 12 (Print Publication: 2022).
Autor:
Lau PKH; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia., Cullinane C; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia., Jackson S; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Walker R; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Smith LK; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia., Slater A; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Kirby L; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Patel RP; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia., von Scheidt B; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Slaney CY; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia., McArthur GA; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia., Sheppard KE; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia.; Department of Biochemistry and Pharmacology, University of Melbourne, Melbourne, VIC 3010, Australia.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Dec 17; Vol. 13 (24). Date of Electronic Publication: 2021 Dec 17.
Autor:
Chan JD; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Lai J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Slaney CY; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Kallies A; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia. axel.kallies@unimelb.edu.au.; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia. axel.kallies@unimelb.edu.au., Beavis PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. paul.beavis@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. paul.beavis@petermac.org., Darcy PK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. phil.darcy@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. phil.darcy@petermac.org.; Department of Pathology, University of Melbourne, Melbourne, Victoria, Australia. phil.darcy@petermac.org.; Department of Immunology, Monash University, Clayton, Victoria, Australia. phil.darcy@petermac.org.
Publikováno v:
Nature reviews. Immunology [Nat Rev Immunol] 2021 Dec; Vol. 21 (12), pp. 769-784. Date of Electronic Publication: 2021 Apr 20.
Autor:
Ali AI; Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Wang M; Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., von Scheidt B; Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia., Dominguez PM; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Harrison AJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia., Tantalo DGM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia., Kang J; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Oliver AJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Chan JD; Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Du X; Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Bai Y; Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Lee B; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Divsion of Systems Biology and Personalised Medicine, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Johnstone RW; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Darcy PK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Kershaw MH; Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia. clare.slaney@petermac.org michael.kershaw@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Slaney CY; Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia. clare.slaney@petermac.org michael.kershaw@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Nov 15; Vol. 27 (22), pp. 6222-6234. Date of Electronic Publication: 2021 Sep 02.
Autor:
Harrison AJ; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia., Du X; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., von Scheidt B; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia., Kershaw MH; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Slaney CY; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
Publikováno v:
Immunotherapy advances [Immunother Adv] 2021 Jul 31; Vol. 1 (1), pp. ltab016. Date of Electronic Publication: 2021 Jul 31 (Print Publication: 2021).
Autor:
Tantalo DG; Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Oliver AJ; Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., von Scheidt B; Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Harrison AJ; Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Mueller SN; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; The Australian Research Council Centre of Excellence in Advanced Molecular Imaging, The University of Melbourne, Melbourne, Victoria, Australia., Kershaw MH; Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia clare.slaney@petermac.org michael.kershaw@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Slaney CY; Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia clare.slaney@petermac.org michael.kershaw@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 May; Vol. 9 (5).
Autor:
Oliver AJ; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia., Darcy PK; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia., Trapani JA; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia., Kershaw MH; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia., Slaney CY; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
Publikováno v:
The FEBS journal [FEBS J] 2021 Jan; Vol. 288 (1), pp. 81-90. Date of Electronic Publication: 2020 Apr 21.
Autor:
Slaney CY; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria 3000, Australia., Kershaw MH; Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria 3000, Australia.
Publikováno v:
Cancers [Cancers (Basel)] 2020 Oct 28; Vol. 12 (11). Date of Electronic Publication: 2020 Oct 28.